Recent developments with Biocryst Pharmaceuticals Inc (BCRX) have led to the company’s beta value being reach 1.09 cents.
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) on Thursday, soared 2.49% from the previous trading day, before settling in for the closing price of $7.22. Within the